Jump to Content

Welcome from the Pro Vice Chancellor

Professor Allan Evans, Pro Vice Chancellor, Division of Health Sciences.In the ever-changing world of health sciences, the Division of Health Sciences at UniSA are moving in step to meet these changes.

The Division seeks to become recognised within Australia and internationally for outstanding leadership and commitment to teaching, research and community services.  Our global links with other international universities open the door to educational opportunities and career choices to you.

We are strongly committed to forming working partnerships and collaborations with business, industry and government. Our Business Development Unit may well be able to offer the services you need. I invite you to take a moment to explore the range of programs and activities that help to make the Division of Health Sciences a fascinating and exciting place to work and study.

Pro Vice Chancellor, Professor Allan Evans


Professor Allan Evans - biography

Allan graduated in 1982 Bachelor of Pharmacy from the South Australian Institute of Technology and in 1989 obtained his PhD in clinical pharmacology from the University of Adelaide. He followed this with post-doctoral experience at the University of Manchester, UK.

Since 1992, he has been an academic at UniSA, taking on various leadership positions and being promoted to Professor in Pharmaceutics in 2003. In 2004 Allan became Head of the School of Pharmacy and Medical Science and played an instrumental role in establishing the Sansom Institute (now the Division-based Sansom Institute for Health Research) and in supporting tremendous growth in the school’s research activity and teaching profile.

Allan has a significant research career. He has more than 90 peer-reviewed publications with over 1,200 literature citations and has held NHMRC and/or ARC grants on an ongoing basis since 1994. His research interests are broad, and include basic, clinical and commercial research into the better use of medicines as well as the development of new ways of using medicines to treat skin cancer and kidney disease. Allan’s group has attracted over $15 million in Category 1-4 research income to UniSA and he continues to manage a number of exciting research projects which regularly lead to invited lectures at overseas conferences.

Allan is currently non-executive Director of two spin-off companies that he helped to form, PharmaQest Pty Ltd and CPR Pharma Services Ltd, and has a keen interest in supporting further engagement between the researchers of the Division and the health, innovation, and medical diagnostic industries. He has continued to teach Pharmacokinetics and Biopharmaceutics P 201 and as a former UniSA course coordinator and program director, is well placed to continue developing the Division’s excellent array of undergraduate and postgraduate programs in health and medical sciences.

top^